These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2004-002799-41 Iontophoresis as a possible therapy for digital ischaemia - preliminary studies in patients with scleroderma spectrum disorders not-yet-due
Ongoing 2005-003775-21 Effects of atorvastatin on microcirculatory endothelial function in patients with systemic sclerosis not-yet-due
Ongoing 2005-003871-19 A randomised control trial to identify the effects of cinacalcet on bone and cardiovascular health in end-stage renal disease not-yet-due
Exempt 2007-002337-36 An open-labelled study of the cerebrospinal fluid pharmacokinetics of intravenous Kineret® in patients with subarachnoid haemorrhage not-yet-due
Not reported 2007-002467-27 Antidyskinetic Properties of Topiramate: A Double-Blind, Placebo-Controlled Trial in Patients with Parkinson's Disease and Levodopa-Induced Dyskinesias 2011-05-31 due-trials
Exempt 2007-005836-98 The effect of Kineret® on brain biomarkers in patients with subarachnoid haemorrhage not-yet-due
Ongoing 2007-007482-21 Multi-center, Open-label Study of the Safety and Efficacy of Control of Proteinuria with ACE Inhibitors and ARBS in Patients with Fabry Diseaswe Who Are receiving Farazyme : Tha Farazyme + Arbs + ACE ... not-yet-due
Ongoing 2009-015849-22 An open label study of intra-articular steroid injection in the management of symptomatic knee OA not-yet-due
Ongoing 2011-001855-35 Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following subarachnoid haemorrhage? not-yet-due
Not reported 2013-001757-28 Does subcutaneous interleukin-1 receptor antagonist reduce inflammation following ischaemic stroke compared to placebo? 2017-02-28 due-trials